Matches in Wikidata for { <http://www.wikidata.org/entity/Q86294817> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q86294817 description "clinical trial" @default.
- Q86294817 description "ensayu clínicu" @default.
- Q86294817 description "klinisch onderzoek" @default.
- Q86294817 description "клінічне випробування" @default.
- Q86294817 name "DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 name "DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 type Item @default.
- Q86294817 label "DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 label "DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 prefLabel "DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 prefLabel "DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 P1050 Q86294817-E0BEAF56-7666-48FF-BE33-2448A666BECD @default.
- Q86294817 P1132 Q86294817-A5C57687-FDAC-44E0-A712-23046D6CAEAA @default.
- Q86294817 P1476 Q86294817-A8777FC2-9710-4B4B-8B2B-47A4E1D02BC4 @default.
- Q86294817 P17 Q86294817-A006596B-25C8-41FA-82AF-34CB799B12E8 @default.
- Q86294817 P2899 Q86294817-C91C1A8D-C3E2-4C6D-BA1B-7D799E4B7FAB @default.
- Q86294817 P3098 Q86294817-2F6FF535-E3CD-4116-913D-F5C1E3DBA0F7 @default.
- Q86294817 P31 Q86294817-C6CE3799-682E-445C-95EE-A08B8B218093 @default.
- Q86294817 P4135 Q86294817-1AFEF9C5-5B41-4F4E-AD4B-1613853CBB7D @default.
- Q86294817 P4844 Q86294817-012F8C05-BFA8-4BFE-90FB-1F6567B36E91 @default.
- Q86294817 P4844 Q86294817-561CDD1F-0A19-4EB4-88A9-52EC19B6D934 @default.
- Q86294817 P4844 Q86294817-5F777A17-569B-4AEB-BAEB-ADB435F527EF @default.
- Q86294817 P580 Q86294817-BEB58EE4-A390-4A61-9A1B-4620C2357A01 @default.
- Q86294817 P582 Q86294817-959F4DFA-3B22-4FEF-BE1E-0B0AB90658DE @default.
- Q86294817 P6099 Q86294817-B6831E9C-F4CD-4D2B-B4DB-C40A5030CC81 @default.
- Q86294817 P767 Q86294817-3EABB24B-01B9-4FCD-B5E6-8D1EE6377C5D @default.
- Q86294817 P8363 Q86294817-A6EB8EE5-6BFD-43BE-AEF7-AB6C573AF531 @default.
- Q86294817 P921 Q86294817-F03D2A74-D5F2-4BC2-92CC-41106739CDA3 @default.
- Q86294817 P921 Q86294817-F97C8E43-51DA-4B02-8179-0942E98ED2D1 @default.
- Q86294817 P1050 Q33525 @default.
- Q86294817 P1132 "+12" @default.
- Q86294817 P1476 "A Pilot Study of a DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma" @default.
- Q86294817 P17 Q30 @default.
- Q86294817 P2899 "+12" @default.
- Q86294817 P3098 "NCT04248569" @default.
- Q86294817 P31 Q30612 @default.
- Q86294817 P4135 "+100" @default.
- Q86294817 P4844 Q2459042 @default.
- Q86294817 P4844 Q7041828 @default.
- Q86294817 P4844 Q7226111 @default.
- Q86294817 P580 "2020-03-01T00:00:00Z" @default.
- Q86294817 P582 "2024-03-01T00:00:00Z" @default.
- Q86294817 P6099 Q5452194 @default.
- Q86294817 P767 Q266423 @default.
- Q86294817 P8363 Q78089383 @default.
- Q86294817 P921 Q2459042 @default.
- Q86294817 P921 Q7041828 @default.